Tag Archives: Cytovia

Cellectis – Cytovia Partnership Expands to Include China

On Thursday, November 18, Cellectis and Cytovia Therapeutics announced (press release) the expansion of their TALEN gene-edited iPSC-derived NK and CAR-NK partnership to enable broader collaboration in China through Cytovia’s joint venture CytoLynx Therapeutics. Below, Celltelligence provides insights on how Cellectis could benefit from the expanded collaboration.

About The Author

The Celltelligence Team

Content Leads & Contributors

The Celltelligence team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

If you receive our email blasts, you already have an account.


You’ll be able to access the full article from your Celltelligence Library after signing up.